Developing antibody-based curative therapies for inflammatory disorders, such as psoriasis and inflammatory bowel disease
Senya Therapeutics is pioneering an anti-leucine-rich α-2 glycoprotein 1 (LRG1) therapeutic platform
Antibodies against a novel transporter target for chronic inflammatory diseases
Extracellular vesicle platform developing novel therapeutics to regenerate tissue in autoimmune diseases